Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing Overview。Artificial Intelligence Drug Discovery Developer Terray Therapeutics Secures $120 Million in Series B FinancingOn October 17, artificial intelligence drug discovery developer Terray Therapeutics secured a $120 million Series B financing round, led by new investor Bedford Ridge Capital and existing investor NVentures, with participation from Maverick Capital, Goldcrest Capital, Madrona Ventures, and others. The funds will advance internal programs into clinical trials and further enhance Terray’s integrated AI platform, tNova, which supports both internal and collaborative projects.Healthcare Workflow Automation Platform Developer Tennr Secures $37 Million in Series B FundingOn October 22, Tennr, a developer of healthcare workflow automation platforms, secured $37 million in Series B funding led by Lightspeed Ventures, with participation from existing investors Andreessen Horowitz and Foundation Capital. This new funding will enable Tennr to continue developing and refining its AI models to enhance accuracy and efficiency, as well as expand sales and marketing efforts to reach more healthcare providers and broaden its impact across the U.S. healthcare system.Digital Physical Therapy Service Platform OneStep Secures $36 Million in FinancingOn October 22, digital physical therapy service platform OneStep secured $36 million in funding, co-led by Team8 and Vintage Investment Partners. This latest round of funding will enable OneStep to expand its reach and influence across the healthcare industry, further develop its technology, enhance its AI-driven platform, and introduce new features.Medical Device Company Okami Medical Secures $32.5 Million in FinancingOn October 21, medical device company Okami Medical secured $32.5 million in financing, led by Vensana Capital, with participation from existing investors including U.S. Venture Partners, members of the Okami board of directors, and other industry veterans. Okami Medical is a private medical device company whose mission is to meet the needs of patients and doctors by developing innovative, versatile, and intuitive peripheral vascular occlusion devices.RAYSHAPE, a Comprehensive Solution Provider for Dental 3D Printing, Secures Over 100 Million Yuan in Series A FundingOn October 24, RAYSHAPE, a comprehensive solution provider for dental 3D printing, secured over 100 million yuan in its Series A round of financing. The round was led by Co-Growth Investment, with participation from several senior entrepreneurs in the dental industry. Index Capital served as the exclusive financial advisor. The proceeds from this round will primarily be used for capacity expansion and overseas market development.Endoscopic Interventional Diagnosis and Treatment Solution Provider Stellar Medical Raises Over 100 Million Yuan in Series B FinancingOn October 23, StarSea Medical, a provider of comprehensive endoscopic interventional diagnosis and treatment solutions, secured over 100 million yuan in its Series B financing round. The investment was led by Origin Capital, with participation from existing shareholders Legend Capital and Daotong Investment. Heryue Capital served as the exclusive financial advisor. This round of funding will enable StarSea Medical to further expand production capacity, accelerate new product development, and enhance global market expansion, driving its rapid growth in the disposable endoscope sector.AI-Assisted Diagnosis and Treatment System Developer Qianglian Zhichuang Secures D+ Round Financing of RMB 100 MillionOn October 21, Qianglian Zhichuang, a developer of AI-assisted diagnosis and treatment systems, secured RMB 100 million in D+ funding round led by Beijing Medical and Health Industry Investment Fund, with participation from Beijing Economic-Technological Development Area Industrial Upgrade Equity Investment Fund. This financing not only represents recognition of the company's technical capabilities and market potential but also provides strong support for Beijing’s strategy to build a world-class biopharmaceutical industry cluster, marking a solid step forward for Qianglian Zhichuang in promoting innovation and development within China’s medical and health industry.Virtual Healthcare Service Provider Counsel Health Secures $11 Million in Seed FundingOn October 22, virtual healthcare service provider Counsel Health secured $11 million in seed funding, led by Andreessen Horowitz (“a16z”) Bio + Health, with participation from Floodgate Fund, Asymmetric Capital Partners, Pear VC, and numerous founders of healthcare startups. Counsel Health will use the funds to enhance its technology, scale its growth, and expand user reach.Digital Health Solutions Provider Minze Health Secures $5.3 Million in FundingOn October 17, digital health solutions provider Minze Health secured $5.3 million in funding, led by White Fund, Capricorn Digital Growth Fund, and PMV, with participation from new investor imec.istart future fund. The proceeds will be used to further develop prescription digital therapeutics (PDT) for patients with urinary dysfunction and bring them to market, as well as to drive Minze's entry into the U.S. market through its home diagnostic solutions.Personalized Surgical Platform Provider Pip Care Secures $5 Million in Series A FundingOn October 17, personalized surgery platform provider Pip Care secured $5 million in Series A funding, led by A1 Health Ventures with participation from UPMC Enterprises. This new funding will enable Pip Care to expand its platform, enhance its technology, and develop new features to further improve the surgical process.02 Digital Health Industry DynamicsGE Healthcare and Hayat National Hospital Establish Partnership to Drive Healthcare Expansion Across Saudi ArabiaGE HealthCare Announces Collaboration with Hayat National Hospitals to Equip Three New Hospitals in Saudi Arabia with Advanced Diagnostic Imaging TechnologyCareDx, a precision medicine company focused on transplant patient solutions, partners with Dovetail Genomics, a leader in genomic solutions, to drive the next wave of innovation in transplant matching using cutting-edge Hi-C technology.CareDx, a precision medicine company focused on transplant patient solutions, and Dovetail Genomics, a leader in genomic solutions, announced a partnership to advance HLA genotyping for organ and stem cell transplantation matching. Through an early access program, HLA laboratories can utilize CareDx’s AlloSeq Tx 17 HLA typing solution, which incorporates Dovetail’s Hi-C LinkPrep technology to enable high-resolution genotyping and haplotyping without the need for family-based genotyping studies. The integration of this haplotyping capability aims to improve the likelihood of long-term donor-recipient matching success.03 Overview of Global Digital Health M&AMedical device manufacturer Werfen completes acquisition of Omixon for approximately $25 millionOn October 20, medical device manufacturer Werfen completed the acquisition of Omixon for approximately $25 million, funded with cash on hand. Omixon, a privately held company headquartered in Budapest, Hungary, focuses on the development and commercialization of NGS technology for transplant diagnostics. This acquisition expands Werfen's portfolio of transplant diagnostic solutions for hospitals and clinical laboratories.Artery Network/Artery Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.
Compiled by: Liu Shuxia
